International Clinical Trial: Immune Decoding-Based Diagnosis of Liver Tumors and Exploration of Immunotherapeutic Targets

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119702) titled 'Immune Decoding-Based Diagnosis of Liver Tumors and Exploration of Immunotherapeutic Targets' on March 2.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: The Affiliated Hospital of Guangdong Medical University

Condition: Hepatocellular Carcinoma?Intrahepatic Cholangiocarcinoma

Intervention: Case Group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-01

Target Sample Size: Case Group:70;Control group:70;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=302984

Published by HT Digi...